SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maulcoin

Maulcoin is trending as the community rallies to boost volume and build organic momentum while awaiting platform-wide ticker and charting support. Investors are actively debating the project's long-term sustainability and transparency, with many sharing bullish sentiment about its potential to disrupt the meme coin space.

What is DAG? In more traditional blockchains, the host provides the food/drinks (i.e resources) for this party. And when the guests arrive, the amount of resources can only accommodate so many people, the portions are small and then everything eventually runs out and the party ends. Think Constellation DAG like a potluck (a party where everyone brings food/drinks). With every added guest (node to the network), the more resources the party has to keep going. This is the nature of Constellation, a distributed system that scales horizontally.  Is Constellation a Blockchain? Not exactly. Although inspired by the principles of decentralization, many standard blockchains such as Bitcoin and Ethereum face scalability issues. This is why the next, generation of decentralized networks such as Hashgraph, IOTA, and Constellation have turned to DAG.  What is a Microservice? “Microservices” is an approach to application development in which a large application is built as a suite of modular services. Each module supports a specific business goal and uses a simple, well-defined interface to communicate with other sets of services. Uber, for example, is not a singular app purse. It is a unified app which means it is a single interface that brings together their driver app, their rider app, and their corporate team app.

Constellation

Constellation (DAG) is trending as investors highlight its unique Layer 0 architecture and high-profile partnerships with U.S. government and defense agencies, including the Department of Defense and Air Force. Community discussions are centered on the project's pivot toward becoming core infrastructure for AI and real-world data validation, with significant buzz surrounding a recent acquisition-led growth strategy and the potential for mass enterprise adoption.

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.

Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals is experiencing significant volatility and heavy trading volume as investors react to a strategic pivot that includes a 40% workforce reduction and an intensified focus on its core ovarian cancer drug trial. Community sentiment is deeply polarized, with active discussions debating whether the stock is a deep-value buyout target trading below its cash-on-hand valuation or a speculative gamble facing long-term dilution risks.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending following a massive $21 billion contract expansion with Meta through 2032 and a new multi-year partnership with Anthropic to power its Claude AI models. While the community is excited about these major AI infrastructure wins and the company's deepening ties to industry leaders, sentiment is being tempered by concerns over the concurrent $3.5 billion convertible note offering and ongoing dilution fears.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing significant volatility and social media attention driven by speculative rumors regarding potential partnerships and high trading volume. While some community members view the token as a promising decentralized platform for the music industry, others are cautious about potential supply releases and the risks of a classic pump-and-dump scenario.

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ and GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Ideaya Biosciences Inc

Ideaya Biosciences is surging as investors anticipate the upcoming topline Phase 2/3 OptimUM-02 trial results for its lead asset, darovasertib, in metastatic uveal melanoma. The community is actively discussing the potential for an accelerated approval filing and a commercial-stage transition, with many traders closely monitoring for high-volume price action and potential institutional accumulation ahead of the data release.

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Organon & Co.

Organon is trending due to speculative M&A headlines involving a potential multibillion-dollar buyout offer from Sun Pharma, leading to intense social media debate over deal credibility and the company's significant debt load. Traders are closely monitoring the high volume and volatility as they weigh the binary risk of a deal announcement against the company's fundamental challenges.

Spire Global, Inc. collects space-based data using a proprietary constellation of low earth multi-use receiver nanosatellites. Its software analytics generate proprietary data, insights and predictive analytics for its customers through a subscription model. The company was founded by Peter Platzer in August 2012 and is headquartered in Vienna, VA.

Spire Global Inc - Ordinary Shares - Class A

Spire Global is trending due to significant institutional interest and anticipation of a major recovery, bolstered by its zero-debt position, recurring revenue model, and potential participation in high-value government defense programs like the S.H.I.E.L.D. contract. Community members are actively discussing a potential short squeeze, rotating capital from the broader space sector, and expressing frustration over management's financial reporting delays, even as they eye a major breakout toward higher price targets.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. (ALOY) is experiencing significant market volatility and trending as traders react to a recent public offering and intense community debate over its long-term viability. Investors are actively discussing the company's defense-sector supply chain role, recent contract news, and the broader implications of US rare earth independence strategies, while skeptics focus on concerns surrounding dilution and the company's pre-revenue status.

iShares Trust - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

The iShares Expanded Tech-Software Sector ETF (IGV) is currently seeing significant volatility and intense debate as investors weigh whether the recent selloff represents a structural collapse driven by AI competition from models like Claude, or a temporary capitulation and generational buying opportunity. Market participants are actively discussing heavy institutional accumulation, elevated short interest, and the sector's resilience as software incumbents focus on integrating AI to defend their dominant market positions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hanover Bancorp, Inc. (NASDAQ:HNVR) Receives Consensus Rating of "Hold" from Analysts

Shares of Hanover Bancorp, Inc. (NASDAQ:HNVR - Get Free Report) have received a consensus rating of "Hold" from the five analysts that are covering the firm, Marketbeat.com reports. One analyst has...

Hanover Bancorp (NASDAQ:HNVR) Stock Price Up 3.9%  - What's Next?

Hanover Bancorp (NASDAQ:HNVR) Trading Up 3.9% - Should You Buy...

Hanover Bancorp, Inc. (NASDAQ:HNVR) Receives Consensus Rating of "Hold" from Brokerages

Shares of Hanover Bancorp, Inc. (NASDAQ:HNVR - Get Free Report) have been given a consensus recommendation of "Hold" by the five research firms that are covering the firm, MarketBeat reports. One...

Hanover Bancorp (NASDAQ:HNVR) Director Sells $11,750.00 in Stock

Hanover Bancorp, Inc. (NASDAQ:HNVR - Get Free Report) Director Robert Golden sold 500 shares of the stock in a transaction on Thursday, February 5th. The shares were sold at an average price of...

Hanover Bancorp (NASDAQ:HNVR) Director Robert Golden Sells 500 Shares

Hanover Bancorp, Inc. (NASDAQ:HNVR - Get Free Report) Director Robert Golden sold 500 shares of the company's stock in a transaction on Thursday, February 5th. The shares were sold at an average...

Insider Selling: Hanover Bancorp (NASDAQ:HNVR) Director Sells 700 Shares of Stock

Hanover Bancorp, Inc. (NASDAQ:HNVR - Get Free Report) Director Robert Golden sold 700 shares of the company's stock in a transaction on Friday, February 6th. The stock was sold at an average price of...

Hanover Bancorp, Inc. (NASDAQ:HNVR) Receives Average Recommendation of "Hold" from Analysts

Hanover Bancorp, Inc. (NASDAQ:HNVR - Get Free Report) has been given an average recommendation of "Hold" by the five ratings firms that are currently covering the company, Marketbeat Ratings reports...

Hanover Bancorp (NASDAQ:HNVR) Releases Earnings Results, Misses Expectations By $0.51 EPS

Hanover Bancorp (NASDAQ:HNVR - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.00 earnings per share (EPS) for the quarter, missing the consensus estimate of...

Hanover Bancorp, Inc. (NASDAQ:HNVR) to Issue $0.10 Quarterly Dividend

Hanover Bancorp, Inc. (NASDAQ:HNVR) announced a quarterly dividend on Thursday, January 29th. Shareholders of record on Thursday, February 12th will be given a dividend of 0.10 per share on Thursday...

Hanover Bancorp, Inc. (HNVR) Reports Break-Even Earnings for Q4

Hanover Bancorp (HNVR) delivered earnings and revenue surprises of -100.00% and -3.15%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Hanover Bancorp, Inc. is a bank holding company, which engages in the provision of financial services and commercial banking products and services. It also offers multi-family and commercial mortgages, residential loans, business loans, and lines of credit. The company was founded in 2008 and is headquartered in Mineola, NY.

Current Price	$22.47
Prev Close	$22.55
Open	$22.68
Dividend Yield	1.73%
50-Day Moving Average	$21.87
Beta	0.48
Avg. Volume	8,813.55
PE Ratio	22.48

52-Week High	$24.36
52-Week Low	$18.60
Market Capitalization	$161.73M
EPS (Annual)	$1.00
Price to Book	0.82
Revenue Per Employee	$738,773.20

HNVR
Hanover Bancorp, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HNVR News

HNVRHanover Bancorp, Inc.